COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,609 Articles (22,913 medRxiv, 8,696 bioRxiv)

Most recent first Previous |  Page 1019: Articles 10181-10190  | Next

Causal associations between body fat accumulation and COVID-19 severity: A Mendelian randomization study
Yoshiji, S., Tanaka, D., Minamino, H., Murakami, T., Fujita, Y., Richards, J. B., Inagaki, N.
10.1101/2022.01.20.22269593 — Posted: 2022-01-21
A booster dose of mRNA-based COVID-19 vaccines fosters the development of an immune response in immunosuppressed fragile patients.
Azzolini, E., Pozzi, C., Germagnoli, L., Oresta, B., Carriglio, N., Calleri, M., Selmi, C., De Santis, M., Finazzi, S., Carlo-Stella, C., Bertuzzi, A., Motta, F., Ceribelli, A., Mantovani, A., Bonelli, F., Rescigno, M.
10.1101/2022.01.21.22269633 — Posted: 2022-01-21
BNT162b2 vaccine boosts neutralizing antibodies to ancestral SARS-CoV-2 & Omicron variant in adults who previously received two doses of inactivated vaccine
Leung, N. H. L., Cheng, S. M. S., Martin-Sanchez, M., Au, N. Y. M., Ng, Y. Y., Luk, L. L. H., Chan, K. C. K., Li, J. K. C., Leung, Y. W. Y., Tsang, L. C. H., Chaothai, S., Kwan, K. K. H., Ip, D. K. M., Poon, L. L. M., Leung, G. M., Peiris, M., Cowling, B. J.
10.1101/2022.01.20.22269586 — Posted: 2022-01-21 Discussion: Offsite
Antigenic determinants of SARS-CoV-2-specific CD4+ T cell lines reveals M protein-driven dysregulation of interferon signaling
Gazzinelli-Guimaraes, P. H., Sanku, G., Sette, A., Weiskopf, D., Schaughency, P., Lack, J., Nutman, T.
10.1101/2022.01.20.22269491 — Posted: 2022-01-21
Capturing intrahost recombination of SARS-CoV-2 during superinfection with Alpha and Epsilon variants in New York City
Wertheim, J. O., Wang, J. C., Leelawong, M., Martin, D. P., Havens, J. L., Chowdhury, M. A., Pekar, J., Amin, H., Arroyo, A., Awandare, G. A., Chow, H. Y., Gonzalez, E., Luoma, E., Morang'a, C. M., Nekrutenko, A., Shank, S. D., Quashie, P. K., Rakeman, J. L., Ruiz, V., Torian, L. V., Vasylyeva, T. I., Kosakovsky Pond, S. L., Hughes, S.
10.1101/2022.01.18.22269300 — Posted: 2022-01-21
"I feel like my body is broken": Exploring the experiences of people living with long COVID
Wurz, A., Culos-Reed, S. N., Franklin, K., DeMars, J., Wrightson, J. G., Twomey, R.
10.1101/2022.01.20.22269617 — Posted: 2022-01-21
Molecular diagnosis of SARS-CoV-2: a validation of saliva samples
da Silva, N. V. R., Pereira, S. S. N., Kavalco, K. F., Menegidio, F. B., Medeiros-Santana, L., Visotto, L. E., Pasa, R.
10.1101/2022.01.20.22269618 — Posted: 2022-01-21
Extreme γ' fibrinogen levels in COVID-19 patients
Farrell, D. H., Hudkins, M., Hamilton, H., Underwood, S. J., Dewey, E. N., Kazmierczak, D. E., Kazmierczak, S. C., Messer, W. B., Khan, A., Schreiber, M. A.
10.1101/2022.01.20.22269321 — Posted: 2022-01-21
Aerosol measurement identifies SARS-CoV 2 PCR positive adults compared with healthy controls
Gutmann, D., Scheuch, G., Lehmkuhler, T., Herrlich, L.-S., Hutter, M., Stephan, C., Vehreschild, M., Khodamoradi, Y., Gossmann, A.-K., King, F., Weis, F., Weiss, M., Rabenau, H. F., Graf, J., Donath, H., Schubert, R., Zielen, S.
10.1101/2022.01.21.22269423 — Posted: 2022-01-21
PBPK-led guidance for the treatment of cystic fibrosis patients taking elexacaftor-tezacaftor-ivacaftor with the newly approved fixed dose combination nirmatrelvir-ritonavir (PAXLOVID) for the treatment of COVID-19
Hong, E., Almond, L. M., Chung, P. S., Rao, A. P., Paul, B. M.
10.1101/2022.01.20.22269253 — Posted: 2022-01-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).